Additional validation study and French cross-cultural adaptation of the Pediatric Stroke Outcome Measure-Summary of Impressions (PSOM-SOI).


Journal

Annals of physical and rehabilitation medicine
ISSN: 1877-0665
Titre abrégé: Ann Phys Rehabil Med
Pays: Netherlands
ID NLM: 101502773

Informations de publication

Date de publication:
May 2021
Historique:
received: 11 10 2019
revised: 28 10 2019
accepted: 28 10 2019
pubmed: 10 12 2019
medline: 21 10 2021
entrez: 10 12 2019
Statut: ppublish

Résumé

The Pediatric Stroke Outcome Measure-Summary of Impressions (PSOM-SOI) measures neurological function across right and left sensorimotor domains (Item A), language production (Item B), language comprehension (Item C), and cognition/behaviour (Item D). This study was a cross-cultural adaptation into French of the PSOM-SOI and an assessment of its reliability and limitations of use. The translation and adaptation of the PSOM-SOI was followed by the assessment of its reliability in a cohort of 69 children with diagnosed acute neonatal arterial ischemic stroke. Three independent raters retrospectively scored the PSOM-SOI based on data from in-person neurological examination and results of standardized tests performed at age 7 in the cohort database. Comparison 1 (C1) involved a less experienced rater and an experienced rater and comparison 2 (C2) involved 2 experienced raters. Inter-rater reliability (IRR) was measured with Kappa coefficients. The cross-cultural adaptation was easily performed, and no rater had difficulties using the French PSOM-SOI. The IRR was better in C1 than C2. For Item A, the agreement in C1 (κ=0.47) and C2 (κ=0.44) was moderate. The C1 agreement was substantial for Items B (κ=0.71) and C (κ=0.70); the C2 agreement was fair for Item B (κ=0.23) and slight for Item C (κ=0.16). For Item D, the agreement was moderate in C1 (κ=0.52) and fair in C2 (κ=0.35). In all but one comparison, agreement or minor disagreement (≤0.5 points) was obtained for more than 90% of the item scores. Regarding the total score, agreement for normal function (≤0.5) versus abnormal function (>0.5) was achieved for 90% in C1 and 67% in C2. The IRR of the French PSOM-SOI gave variable results depending on the item and rater's experience, but the extent of disagreements was minor for individual items and total score. Additional prospective validation studies using the French PSOM-Short Neurological Exam to score the PSOM-SOI are needed. A dichotomised total score (cut-off≤0.5) could be used to define normal function versus poor outcome.

Sections du résumé

BACKGROUND BACKGROUND
The Pediatric Stroke Outcome Measure-Summary of Impressions (PSOM-SOI) measures neurological function across right and left sensorimotor domains (Item A), language production (Item B), language comprehension (Item C), and cognition/behaviour (Item D).
OBJECTIVE OBJECTIVE
This study was a cross-cultural adaptation into French of the PSOM-SOI and an assessment of its reliability and limitations of use.
MATERIAL AND METHODS METHODS
The translation and adaptation of the PSOM-SOI was followed by the assessment of its reliability in a cohort of 69 children with diagnosed acute neonatal arterial ischemic stroke. Three independent raters retrospectively scored the PSOM-SOI based on data from in-person neurological examination and results of standardized tests performed at age 7 in the cohort database. Comparison 1 (C1) involved a less experienced rater and an experienced rater and comparison 2 (C2) involved 2 experienced raters. Inter-rater reliability (IRR) was measured with Kappa coefficients.
RESULTS RESULTS
The cross-cultural adaptation was easily performed, and no rater had difficulties using the French PSOM-SOI. The IRR was better in C1 than C2. For Item A, the agreement in C1 (κ=0.47) and C2 (κ=0.44) was moderate. The C1 agreement was substantial for Items B (κ=0.71) and C (κ=0.70); the C2 agreement was fair for Item B (κ=0.23) and slight for Item C (κ=0.16). For Item D, the agreement was moderate in C1 (κ=0.52) and fair in C2 (κ=0.35). In all but one comparison, agreement or minor disagreement (≤0.5 points) was obtained for more than 90% of the item scores. Regarding the total score, agreement for normal function (≤0.5) versus abnormal function (>0.5) was achieved for 90% in C1 and 67% in C2.
CONCLUSION CONCLUSIONS
The IRR of the French PSOM-SOI gave variable results depending on the item and rater's experience, but the extent of disagreements was minor for individual items and total score. Additional prospective validation studies using the French PSOM-Short Neurological Exam to score the PSOM-SOI are needed. A dichotomised total score (cut-off≤0.5) could be used to define normal function versus poor outcome.

Identifiants

pubmed: 31816450
pii: S1877-0657(19)30189-7
doi: 10.1016/j.rehab.2019.10.010
pii:
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

101341

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

Marie-Doriane Morard (MD)

Département de médecine physique et de réadaptation pédiatrique, hôpital femme-mère-enfant, hospices civils de Lyon, 69500 Bron, France; UMR 1059 SAINBIOSE, Inserm et université de Lyon, 42023 Saint-Étienne, France. Electronic address: marie-doriane.morard@chu-lyon.fr.

Mickael Dinomais (M)

Département de médecine physique et de réadaptation, université d'Angers, CHU d'Angers 49933 Angers, France; Laboratoire Angevin de recherche en ingénierie des systèmes (LARIS)-EA7315, université Angers, 49933 Angers, France.

Kim Bull (K)

Clinical and experimental sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.

Pascal Rippert (P)

Pôle de santé publique, hospices civils de Lyon, 69003 Lyon, France.

Mathilde Chevignard (M)

Département de rééducation des pathologies neurologiques acquises de l'enfant, hôpitaux de Saint-Maurice, 94410, Saint-Maurice, France; UMR 7371, UMR_S 1146, LIB, Sorbonne Université, UPMC Université Paris 06, 75005 Paris, France.

Gabrielle deVeber (G)

Division of Neurology, Hospital for sick children, Child Health Evaluative Sciences Program, 555, University Ave, M5G1X8 Toronto, ON, Canada.

Stéphane Chabrier (S)

UMR 1059 SAINBIOSE, Inserm et université de Lyon, 42023 Saint-Étienne, France; Inserm CIC1408, département de médecine physique et de réadaptation pédiatrique, centre national de référence de l'AVC de l'enfant, CHU de Saint-Étienne, 42055 Saint-Étienne, France.

Carole Vuillerot (C)

Département de médecine physique et de réadaptation pédiatrique, hôpital femme-mère-enfant, hospices civils de Lyon, 69500 Bron, France; CNRS UMR 5558, laboratoire de biométrie et biologie évolutive, équipe bio statistique santé, 69310 Pierre-Bénite, France; Université Lyon I, 69100 Villeurbanne, France; Université de Lyon, 69000 Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH